COMP <GO>
IDXG vs UNP // RETURN ON INVESTED CAPITAL (ROIC)
Interpace Biosciences Inc. (NASDAQ) VS. Union Pacific Corporation (NYSE) • 15-METRIC TALLY: IDXG 3
— UNP 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: UNP
LAST: $5.72 (+15.56%) • MKT CAP: $23.2M
roic
16.20%
LAST: $301.93 (+1.39%) • MKT CAP: $179.42B
roic
20.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDXG VS. UNP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDXG | UNP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 16.20% | 20.10% | -3.90 | UNP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.7x | 15.3x | -10.60 | IDXG | /valuation <GO> |
| Free Cash Flow Yield | 23.60% | 3.06% | +20.54 | IDXG | /fcf-yield <GO> |
| Operating Margin | 10.50% | 40.20% | -29.70 | UNP | /operating-margins <GO> |
| Net Profit Margin | 63.50% | 29.10% | +34.40 | IDXG | /net-margins <GO> |
| Revenue Growth (YoY) | -17.50% | 1.10% | -18.60 | UNP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.80% | -1.80 | UNP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.31 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 66.2 | -16.25 | UNP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.03 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $23.2M | $179.42B | -$179.40B | UNP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDXG REV | UNP REV | IDXG GROSS % | UNP GROSS % | IDXG FCF | UNP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.7M | $24.51B | 62.3% | — | $5.5M | $5.50B |
| FY 2024 | $46.9M | $24.25B | 63.8% | — | $3.8M | $5.89B |
| FY 2023 | $40.0M | $24.12B | — | — | $3.8M | $7.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDXG // BETA —
UNP // BETA 1.03